Sixteen federal lawsuits alleging persistent sexual dysfunction, allegedly caused by Propecia, were centralized on Tuesday, April 16th, before Federal Judge John Gleeson in New York.
The federal Judicial Panel on Multidistrict Litigation found that 16 Propecia lawsuits involve common questions of fact that make consolidated discovery logical: “All the actions involve allegations that use of Propecia (finasteride) causes persistent sexual dysfunction in a subset of men who took the drug, even after they discontinued its use…. Centralization will eliminate duplicative discovery; prevent inconsistent pretrial rulings; and conserve the resources of the parties, their counsel, and the judiciary.”
As I wrote on Tuesday, the FDA has increased Propecia’s sexual side effect risk to Propecia to include reports of libido, ejaculation, and orgasm disorders that continue after Propecia has been discontinued.
I titled this post Propecia Class Action Lawsuit. That’s a little misleading (mostly to attract searchers looking for “class action”). The Propecia MDL is a class action in the sense that the cases will have common discovery for fact witnesses and documents that would be common to every Propecia sexual dysfunction lawsuit. But, this is not a classic class action because the cases will not be tried together. After discovery, the cases will be remanded to the federal court in which the cases will be tried for case specific discovery and trial.
To learn more about whether you may have a Propecia lawsuit, click here.